InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Daniel Rankin. Director active across 1 company, notably Swedish Orphan Biovitrum AB (publ). Aggregated, 4 filings have been recorded. History available since 28 October 2025. The latest transaction was filed on 12 June 2026 (Sale). Regulator: FIN-FSA. The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条